Skip to main content
. Author manuscript; available in PMC: 2015 Aug 15.
Published in final edited form as: Clin Cancer Res. 2014 Jun 9;20(16):4176–4185. doi: 10.1158/1078-0432.CCR-13-2024

Figure 2.

Figure 2

Figure 2

A. Overall survival according to sex and performance status. Cooperative group trials in advanced pancreatic cancer with regimens containing Gemcitabine. N=1,046 cases with complete data for sex and performance status. B. Progression free survival according to performance status and sex. Cooperative group trials in advanced pancreatic cancer with regimens containing Gemcitabine. N=1,046 cases with complete data for performance status, NCCTG-034A excluded. Abbreviation: PS, performance status.